SIGNiX Launches E-Signatures Solutions that Align to SAFE-BioPharma Global Standard
FREMONT,CA: SIGNiX, provider of cloud-based Independent E-Signatures, announced the launched of its e-signature solutions that adhere to the SAFE-BioPharma global standard. The enhanced e-signature solutions enable life sciences, pharmaceutical and healthcare companies to authorize agreements that meet legal and regulatory standards across the world.
SIGNiX and SAFE-BioPharma has extended its platform to continue to give high assurance identity and signing credentials across the board, particularly as an add-on feature to SIGNIX’S PharmaDoX solutions for users in the life sciences industry and to its MyDox solution for healthcare and other enterprise users.
SIGNiX’s new SAFE-BioPharma-complaint technology provides a unique digital certificate, or identity, certified by SAFE-BioPharma. Its signature and certificates will be recognized and trusted by U.S government agency applications within Europe and European Medicines Agency as a qualified electronic signature.
“SIGNiX has developed an outstanding enhancement to their solutions that are both intuitive and exceedingly secure. This will certainly have a significant impact on companies looking for a more productive, cost-effective and secure way to conduct transactions and submissions,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association.
SIGNiX’s e-signature solutions include: robust workflow options to get documents signed by parties anytime; easy to use-browser-based interface to sign documents, mobile devices, tablets and PCs; a cloud based service and signature is valid for the life of a document; published legal Independent e-signature technology based on the international standards and is secure with rich evidence based on the signature’s validity which is permanently embedded directly into the signed document; tamper-evident technology and comprehensive audit trails to provide complete transparency of the signing process.
“Our SAFE-BioPharma-compliant e-signatures give healthcare, life sciences and pharmaceutical companies a secure, convenient tool for authorizing transactions worldwide and accelerates their ability to establish fully electronic environments. We applaud the SAFE-BioPharma Association for developing this global identity and signature standard and are honored to be a partner of the association,” said Jay Jumper, president and CEO, SIGNiX.
By James Seevers, CIO & GM, Toyoda Gosei
By Bill Krivoshik, SVP & CIO, Time Warner Inc.
By Gregory Morrison, SVP & CIO, Cox Enterprises
By Alberto Ruocco, CIO, American Electric Power
By Bruce. D. Smith, SVP & CIO, Information Systems, Advocate...
By Adrian Mebane, VP-Global Ethics & Compliance, The Hershey...
By Graham Welch, Director-Cisco Security, Cisco
By Michael Watkins, Senior Product Director, Global Knowledge
By Bernd Schlotter, President of Services, Unify
By Patrick Hale, CIO, VITAS Healthcare
By Steve Bein, VP-GIS, Michael Baker International
By Jason Alan Snyder, CTO, Momentum Worldwide
By Mike Morris, CIO, Legends
By Louis Carr, Jr., CIO, Clark County
By Bill Dow, SVP and General Manager of Business Solutions,...
By Jim Whitehurst, CEO, Red Hat
By Darren Cockrel, CIO, Coyote Logistics, a UPS Company...
By Nathan Johnson, SVP and CIO, Werner Enterprises [NASDAQ:...
By David Tamayo, CIO, DCS Corporation
By Neil Hampshire, CIO, ModusLink Global Solutions, Inc....